0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Radiotherapy

Not currently available

Chemotherapy and Radiotherapy of Gastrointestinal Tumors (Paperback, Softcover reprint of the original 1st ed. 1981) Loot Price: R2,264
Discovery Miles 22 640
Chemotherapy and Radiotherapy of Gastrointestinal Tumors (Paperback, Softcover reprint of the original 1st ed. 1981): H O Klein

Chemotherapy and Radiotherapy of Gastrointestinal Tumors (Paperback, Softcover reprint of the original 1st ed. 1981)

H O Klein

Series: Recent Results in Cancer Research, 79

 (sign in to rate)
Loot Price R2,264 Discovery Miles 22 640 | Repayment Terms: R212 pm x 12*

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

Attempts to influence survival of patients with colorectal cancer (CRC) by adjuvant chemotherapy are limited by the variability of survival in different prognostic groups [4] and the paucity of drugs that have shown activity in the advanced disease [10]. Of the few drugs which are active in the advanced disease, only 5-fluorouracil (5-FU) and razoxane "+/-1,2-bis(3,4-dioxopiperazin-1-yl)propane) are suitable for long-term adjuvant treatment [2, 9]. 5-FU has been widely and intensively studied as adjuvant chemotherapy in CRC [7], but there is no unanimity that it has even the marginal influence on survival that has been claimed [3, 10]. Razoxane has not previously been tested for adjuvant or maintenance treatment in CRC. It has however a number of biological activities which might be thought useful in the treatment of residual or minimal tumours [1] and which might therefore make it useful as an adjuvant. Thus it specifically prevents tumour dissemination and metastases in some tumours and normalizes the neovasculature which the tumours induce [6, 8, 11]. The drug is not cytotoxic in the usual sense, does not affect non-dividing cells, and only blocks cell division during a brief period of the cell cycle in late G and/or early mitosis [12]. It does so non-selectively and most cells capable of 2 division examined so far have been affected by the drug. Even affected cells however are not destroyed immediately, but may increase in size and become multinucleate [5].

General

Imprint: Springer-Verlag
Country of origin: Germany
Series: Recent Results in Cancer Research, 79
Release date: December 2011
First published: 1981
Editors: H O Klein
Dimensions: 244 x 170 x 6mm (L x W x T)
Format: Paperback
Pages: 112
Edition: Softcover reprint of the original 1st ed. 1981
ISBN-13: 978-3-642-81683-3
Categories: Books > Medicine > Clinical & internal medicine > Gastroenterology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Radiotherapy
LSN: 3-642-81683-5
Barcode: 9783642816833

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Practical Radiotherapy Planning - Fifth…
Stephen Morris, Tom Roques, … Hardcover R3,118 Discovery Miles 31 180
Proton Beam Therapy - How Protons are…
Santosh Yajnik Hardcover R4,438 Discovery Miles 44 380
Lung Cancer - Treatment and Research
Karen L. Reckamp Hardcover R5,674 Discovery Miles 56 740
Intensity-Modulated Radiation Therapy…
Yasumasa Nishimura, Ritsuko Komaki Hardcover R5,242 Discovery Miles 52 420
Interstitial Prostate Brachytherapy…
Gyoergy Kovacs, Peter Hoskin Hardcover R3,865 Discovery Miles 38 650
Dating Neurological Injury: - A Forensic…
Jeff L. Creasy Hardcover R4,243 Discovery Miles 42 430
Radiation Therapy for Skin Cancer
Armand B. Cognetta, William M. Mendenhall Hardcover R5,295 Discovery Miles 52 950
Radiotherapy and Brachytherapy
Yves Lemoigne, Alessandra Caner Hardcover R7,353 R6,263 Discovery Miles 62 630
Materia Medica for Various Cancers
William C.S. Cho Hardcover R7,642 Discovery Miles 76 420
Increasing the Therapeutic Ratio of…
Philip J. Tofilon, Kevin Camphausen Hardcover R5,426 R4,944 Discovery Miles 49 440
Targeted Radionuclide Tumor Therapy…
Torgny Stigbrand, Jorgen Carlsson, … Hardcover R6,281 Discovery Miles 62 810
Molecular Radio-Oncology
Michael Baumann, Mechthild Krause, … Hardcover R3,488 Discovery Miles 34 880

See more

Partners